Skip to content

Clinical trials

Phase 4 Disorders of Excessive Somnolence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disorders of Excessive Somnolence Phase: Phase 4 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20081
20092
20103
20131
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cephalon3
University of Cincinnati2
Amsterdam UMC, location VUmc1
Axsome Therapeutics, Inc.1
Charles A. Czeisler, PhD, MD1
Jazz Pharmaceuticals1
Mayo Clinic1
Milton S. Hershey Medical Center1
The Cleveland Clinic1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disorders of Excessive Somnolence14
Sleep Apnea, Obstructive4
Dysthymic Disorder1
Epilepsies, Partial1
Gastroesophageal Reflux1
Idiopathic Hypersomnia1
Lewy Body Disease1
Major Depressive Disorder1
Narcolepsy1
Parkinson Disease1

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.